Pharmaceutical News

RSS

FDA issues import alert on drug products manufactured at Ranbaxy's facility in Mohali, India

The U.S. Food and Drug Administration today issued an import alert under which U.S. officials may detain at the U.S. border drug products manufactured at Ranbaxy Laboratories, Ltd.'s facility in Mohali, India.

17 Sep 2013

Vanderbilt examines ability of drug abatacept to prevent type 1 diabetes

Vanderbilt's Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D.

17 Sep 2013

First generic version of Xeloda gets FDA approval for breast and colorectal cancers

The U.S. Food and Drug Administration today approved the first generic version of Xeloda (capecitabine), an oral chemotherapy pill used to treat cancer of the colon or rectum (colorectal cancer) that has spread to other parts of the body (metastatic), and metastatic breast cancer.

17 Sep 2013

Neuroprotective effects of rutaecarpine on cerebral ischemia reperfusion injury

Rutaecarpine, an active component of the traditional Chinese medicine Tetradium ruticarpum, has been shown to improve myocardial ischemia reperfusion injury, mainly focusing on calcitonin gene-based targets.

17 Sep 2013

Sigma-Tau Pharmasource, Aradigm Ink Manufacturing Deal For Respiratory Disease Treatment

...

16 Sep 2013

New website aims to reduce negative impact of amphetamine use

Reducing the negative impact of amphetamine use is the aim of a new website launched by a Griffith University PhD candidate, in the face of this significant drug problem.

16 Sep 2013

FDA grants orphan drug designation to Soligenix’s SGX94 for treatment of Acute Radiation Syndrome

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today that the Office of Orphan Products Development of the US Food and Drug Administration (FDA) has granted orphan drug designation to the active ingredient SGX94 for the treatment of acute radiation syndrome (ARS).

16 Sep 2013

Relmada Therapeutics collaborates with the Malvern Consulting Group

Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced that has signed a collaboration agreement with the Malvern Consulting Group as clinical and regulatory advisor.

16 Sep 2013

GrowLife opens 7th hydroponic retail in Santa Rosa, CA

GrowLife, Inc., a provider of highly effective indoor growing technologies and unique lifestyle brands, is pleased to announce that the Company will open its 7th hydroponic retail location in Santa Rosa, CA in October.

16 Sep 2013

Kinder chemistry promises cleaner and safer pharmaceuticals with fewer side-effects

A new and kinder chemistry promises cleaner and subsequently safer pharmaceuticals with fewer side-effects. The ground-breaking method, developed by a chemistry research group at the University of Copenhagen, is now published in the internationally renowned journal, Chemical Communications, as "Site-selective three component reaction for dual functionalization of peptides".

16 Sep 2013

Electronic data can be used as warning system for missed doses of prescribed medicine

Electronic data routinely gathered in hospitals can be used as a warning system for missed doses of prescribed medicine and making improvements to patient safety, says a new study.

16 Sep 2013

Combination therapies: Cost-effective alternative to treat visceral leishmaniasis

Visceral leishmaniasis is the second-deadliest parasitic disease after malaria. Each year, thousands fall victim among poor and marginalised populations in low-income countries.

16 Sep 2013

Study: Opioid prescribing for non-cancer pain increases

Prescribing of strong opioid medications for non-cancer pain in the United States has nearly doubled over the past decade, reports a study in the October issue of Medical Care, published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

16 Sep 2013

Drug used in patients for cancer treatment has beneficial effects on diabetes

A pair of studies by researchers at the Stanford University School of Medicine has identified a molecular pathway - a series of interaction among proteins - involved in the development of diabetes. Furthermore, they have found that a drug already approved for use in humans can regulate the pathway.

16 Sep 2013

Research findings bring scientists one step closer to preventing HIV infections

In a long-awaited finding, a team of Chinese and US scientists has determined the high-resolution atomic structure of a cell-surface receptor that most strains of HIV use to get into human immune cells. The researchers also showed where maraviroc, an HIV drug, attaches to cells and blocks HIV’s entry.

13 Sep 2013

Study evaluates effectiveness of new meningitis serogroup A vaccine in sub-Saharan Africa

Evaluation of the effectiveness of a mass vaccination campaign with a new meningitis serogroup A vaccine, PsA-TT, in sub-Saharan Africa found that it had a dramatic impact on cases of serogroup meningitis and on carriage of the disease-causing bacteria in the throat, according to new research published in The Lancet.

13 Sep 2013

MenAfriVac reduces incidence of meningitis by 94%

A new meningitis vaccine (MenAfriVac) is highly effective at protecting against epidemic A meningococcal disease, common in Africa’s meningitis belt where it accounts for at least three quarters of cases, and against transmission of the bacterium that causes these epidemics, according to new research published in The Lancet.

13 Sep 2013

Pharmaceutical News

FDA issues import alert on drug products manufactured at Ranbaxy's facility in Mohali, India

Vanderbilt examines ability of drug abatacept to prevent type 1 diabetes

First generic version of Xeloda gets FDA approval for breast and colorectal cancers

Neuroprotective effects of rutaecarpine on cerebral ischemia reperfusion injury

Sigma-Tau Pharmasource, Aradigm Ink Manufacturing Deal For Respiratory Disease Treatment

New website aims to reduce negative impact of amphetamine use

FDA grants orphan drug designation to Soligenix’s SGX94 for treatment of Acute Radiation Syndrome

Relmada Therapeutics collaborates with the Malvern Consulting Group

GrowLife opens 7th hydroponic retail in Santa Rosa, CA

Kinder chemistry promises cleaner and safer pharmaceuticals with fewer side-effects

Electronic data can be used as warning system for missed doses of prescribed medicine

Combination therapies: Cost-effective alternative to treat visceral leishmaniasis

Study: Opioid prescribing for non-cancer pain increases

Drug used in patients for cancer treatment has beneficial effects on diabetes

Research findings bring scientists one step closer to preventing HIV infections

Study evaluates effectiveness of new meningitis serogroup A vaccine in sub-Saharan Africa

MenAfriVac reduces incidence of meningitis by 94%

Scientists discover promising potential drug target for cystic fibrosis

Nanodiamonds deliver chemotherapy directly into brain tumors

Using large doses of codeine may heighten sensitivity to pain

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News